Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
If a patient receives exactly 1000 mcg, bill one unit
April 8 Product: Supernus Pharmaceuticals SPN-830 Indication: Parkinsons disease Supernus Pharmaceuticals failed, for the second time, to secure approval for its drug-device combo SPN-830, which is intended for the continuous treatment of motor fluctuations in Parkinsons disease
While it was originally studied for human use, its now being explored in veterinary medicine for its regenerative properties in dogs
Thymosin Alpha-1 Peptide One of the most useful peptides, Thymosin alpha-1, was originally extracted from the thymus gland
US$ 26.25
US$ 26.62
US$ 27.20
US$ 28.24
US$ 24.44
US$ 21.31
US$ 27.00
US$ 22.39
US$ 20.21
US$ 29.75
US$ 29.00
US$ 20.75
US$ 20.27
US$ 24.23
